Inogen Inc Stock Today
| INGN Stock | USD 9.63 0.03 0.31% |
Performance0 of 100
| Odds Of DistressLess than 13
|
Inogen is selling at 9.63 as of the 28th of November 2024; that is 0.31 percent increase since the beginning of the trading day. The stock's open price was 9.6. Inogen has less than a 13 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Inogen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 14th of February 2014 | Category Healthcare | Classification Health Care |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 23.82 M outstanding shares of which 826.34 K shares are currently shorted by private and institutional investors with about 3.56 trading days to cover. More on Inogen Inc
Moving together with Inogen Stock
Moving against Inogen Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Inogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Bart Sanford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Baby Boomer Prospects, Obamacare Repeal, Trump Equities, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInogen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inogen's financial leverage. It provides some insight into what part of Inogen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inogen Inc (INGN) is traded on NASDAQ Exchange in USA. It is located in 859 Ward Drive, Goleta, CA, United States, 93111 and employs 834 people. Inogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 228.66 M. Inogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 23.82 M outstanding shares of which 826.34 K shares are currently shorted by private and institutional investors with about 3.56 trading days to cover.
Inogen Inc currently holds about 223.62 M in cash with (3.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership AllocationInogen Inc has a total of 23.82 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Inogen Ownership Details
Inogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-09-30 | 554.2 K | |
| State Street Corp | 2024-06-30 | 497 K | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 484.6 K | |
| Renaissance Technologies Corp | 2024-09-30 | 417.9 K | |
| New York State Common Retirement Fund | 2024-09-30 | 410.3 K | |
| Federated Hermes Inc | 2024-09-30 | 346 K | |
| Jane Street Group Llc | 2024-06-30 | 301.4 K | |
| Jacobs Levy Equity Management, Inc. | 2024-09-30 | 290.9 K | |
| Kent Lake Capital Llc | 2024-06-30 | 289.7 K | |
| Camber Capital Management Llc | 2024-09-30 | 2 M | |
| Blackrock Inc | 2024-06-30 | 1.6 M |
Inogen Historical Income Statement
Inogen Stock Against Markets
Inogen Corporate Management
| Nabil Shabshab | Pres CEO | Profile | |
| Vijay Paliwal | Senior Enablement | Profile | |
| Adrien Mithalal | Senior Development | Profile | |
| Agnes Lee | VP Planning | Profile | |
| Philip Corrin | Senior Chain | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (2.25) | Revenue Per Share 14.095 | Quarterly Revenue Growth 0.058 | Return On Assets (0.1) |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.